Literature DB >> 6980256

Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.

K Welte, C Y Wang, R Mertelsmann, S Venuta, S P Feldman, M A Moore.   

Abstract

Interleukin 2 (IL-2), produced with and without co-stimulation by the Burkitt's lymphoma line Daudi, was purified 37,000-fold to apparent homogeneity from lymphocyte conditioned medium by (NH4)2SO4 precipitation, DEAE-cellulose ion-exchange chromatography, gel filtration, and chromatography on blue agarose and on Procion-red agarose. The purified IL-2 showed a 10(6) U/mg protein sp act. IL-2 produced in the absence of Daudi cells had a mol wt of 26,000 as measured by gel filtration and an isoelectric point of 6.7. This IL-2 showed a 16,000 and 17,000 mol wt in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). IL-2, produced in the presence of Daudi cells (10(6)/ml), showed a mol wt of approximately 14,000, as measured by both gel filtration and SDS-PAGE, and an isoelectric point of 8.1. The purified IL-2 lacked detectable interferon (alpha and gamma), granulocyte-macrophage colony-stimulating factor, B cell growth factor, T cell-replacing factor, and thymocyte-differentiating activity and was free of any contaminating proteins as judged by silver staining in SDS-PAGE. All three molecular forms of IL-2 were biologically active at concentrations of 10(-11) - 10(-10) M, supporting the growth of human and murine cytotoxic T cell lines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980256      PMCID: PMC2186775          DOI: 10.1084/jem.156.2.454

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and a highly sensitive silver stain.

Authors:  C R Merril; R C Switzer; M L Van Keuren
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Purification to apparent homogeneity of murine interleukin 1.

Authors:  S B Mizel; D Mizel
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

6.  Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.

Authors:  S Gillis; K A Smith; J Watson
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

Review 7.  The nature and action of granulocyte-macrophage colony stimulating factors.

Authors:  A W Burgess; D Metcalf
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

Review 8.  Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes.

Authors:  F W Ruscetti; R C Gallo
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

9.  Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media.

Authors:  J W Mier; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.

Authors:  J Watson; S Gillis; J Marbrook; D Mochizuki; K A Smith
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  32 in total

1.  [Growth factors. A new dimension in understanding oncogenesis].

Authors:  V Heinemann; U Jehn
Journal:  Klin Wochenschr       Date:  1985-08-16

2.  Phosphorylation of human interleukin-2 (IL-2).

Authors:  H F Kung; I Calvert; E Bekesi; F R Khan; K P Huang; S Oroszlan; L E Henderson; T D Copeland; R C Sowder; S J Wei
Journal:  Mol Cell Biochem       Date:  1989-08-15       Impact factor: 3.396

3.  Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.

Authors:  T Uchiyama; Y Kamagata; X J Yan; A Kawachi; H Fujikawa; H Igarashi; M Okubo
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

4.  Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.

Authors:  H Takematsu; H Tagami
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

5.  The glycoprotein nature and biosynthetic relationship of two molecularly distinct species of primate T-cell growth factor.

Authors:  D S Milstone; C W Parker
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

Review 6.  Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms.

Authors:  J Atzpodien; H Kirchner
Journal:  Klin Wochenschr       Date:  1990-01-04

7.  Characterization of human interleukin 2 derived from Escherichia coli.

Authors:  S M Liang; B Allet; K Rose; M Hirschi; C M Liang; D R Thatcher
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

8.  Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed mice.

Authors:  V J Merluzzi; K Welte; R H Mertelsmann; L Souza; T Boone; K Last-Barney
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

9.  Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency.

Authors:  G Kruger; K Welte; N Ciobanu; C Cunningham-Rundles; P Ralph; S Venuta; S Feldman; B Koziner; C Y Wang; M A Moore
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

10.  Leukaemia x fibroblast hybrid cells augment the antibody response to sheep red blood cells in inbred mice.

Authors:  E P Cohen; K Hagen
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.